These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation.
    Author: Ramirez-Guerrero G, Sevillano Prieto AM, Jara-Vilugrón F, Polanco Fernandez N, Gonzalez Monte E, Henandez Vicente A, Rodriguez Gayo LC, Praga Terente M, Andrés Belmonte A.
    Journal: Transfus Apher Sci; 2021 Apr; 60(2):103046. PubMed ID: 33455879.
    Abstract:
    The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30 % of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20 %-40 % of the affected patients are refractory or presents frequents relapses. In this paper we describe the evolution of three recipients treated with long-term plasmapheresis therapy after a recurrence of FSGS with a bad or incomplete response to other treatments. Although our findings require confirmation, long-term plasmapheresis could be a therapeutic option for this condition.
    [Abstract] [Full Text] [Related] [New Search]